Literature DB >> 6969999

Success of medical and surgical management of acute variceal hemorrhage.

J M Holman, L F Rikkers.   

Abstract

Peripheral intravenous Pitressin infusion, use of the Sengstaken-Blakemore tube, or both effectively controlled variceal hemorrhage in 69 percent of patients, allowing an interval of medical management before elective portasystemic shunt surgery. Prolonged preoperative in-hospital management significantly improved hepatic function in initially poor risk patients. This improvement in hepatic function appeared to result in decreased postoperative morbidity and an operative mortality equal to that of good risk patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969999     DOI: 10.1016/0002-9610(80)90124-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Effect of salvianolic acid B and paeonol on blood lipid metabolism and hemorrheology in myocardial ischemia rabbits induced by pituitruin.

Authors:  Qian Yang; Siwang Wang; Yanhua Xie; Jianbo Wang; Hua Li; Xuanxuan Zhou; Wenbo Liu
Journal:  Int J Mol Sci       Date:  2010-09-28       Impact factor: 5.923

Review 2.  Surgical management of acute variceal hemorrhage.

Authors:  L F Rikkers; G Jin
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

3.  Scrotal and abdominal skin necrosis complicating intravenous vasopressin therapy for bleeding esophageal varices.

Authors:  H K Gogel; R W Sherman; L E Becker
Journal:  Dig Dis Sci       Date:  1985-05       Impact factor: 3.199

Review 4.  Operations for management of esophageal variceal hemorrhage.

Authors:  L F Rikkers
Journal:  West J Med       Date:  1982-02

5.  Protective effects of Shexiang Tongxin Dropping Pill on pituitrin‑induced acute myocardial ischemia in rats.

Authors:  Shan Lin; Jianfeng Chu; Ling Zhang; Daxin Chen; Fei Xiao; Hongwei Chen; Jiumao Lin; Youqin Chen; Yuling Zhu; Jun Peng
Journal:  Mol Med Rep       Date:  2017-07-13       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.